
Cancer. The body changes. The terrain changes. The rules change. Making sense of biological shifts in remission through lived experience and structured reasoning.
| Platform | Pricing | Freemium | Publishes | Daily | |
|---|---|---|---|---|---|
| Issues | 36 | Founded | 5 months ago | Last Issue | 7 days ago |
| Active | |||||

As part of the series the ABCs of Cancer Biology, we have arrived at C. Cancer stem cells, or CSCs, are a key (and unfortunate) part of cancer biology and progression.
When a tumor is gone and the scans show no evidence of disease (NED), t...
Cell cycle arrest, zombie cells and is apigenin really right for everyone? From research to practical applications.
Apigenin is a flavonoid found in parsley, celery, chamomile, oregano and some citrus fruits. Chamomile tea is one of the ri...
Tumors were supposed to be sterile. No bacteria growing on them. That was the assumption for decades. Immune cells constantly patrol nearby tissue, ready to clear out anything foreign. Not exactly a welcoming spot for microbes.
Turns out t...
A weekend read: Today I’d like to step back from cancer biology and talk about something every patient experiences but few people discuss.
Integrative oncology often focuses on nutrition, exercise, supplements, sleep and stress reduction....
What integrative oncology has learned about one of cancer's most important hallmarks.
In Part 1 of The ABCs of Cancer Biology, we covered angiogenesis, the process tumors use to build their own blood supply. Without it, most solid tumors r...
Subscribers, engagement, traffic and sponsorship for The Cancer Strategist.
| Subscribers | Engagement | 79 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
The writers behind this newsletter.
Integrative cancer strategies: what works, what doesn’t and what can backfire. Double MSc, analyst — I look at what the research says and what life actually teaches. From diagnosis to remission, I’m tracking this in real time.
You can find recent issues that have been published by The Cancer Strategist on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to The Cancer Strategist, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch The Cancer Strategist as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact The Cancer Strategist using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like The Cancer Strategist. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.